#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Cardiac failure acute Haemophagocytic lymphohistiocytosis Small cell lung cancer recurrent Glycogen storage disease type V Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Chronic inflammatory demyelinating polyradiculoneuropathy Chronic graft versus host disease Hereditary haemorrhagic telangiectasia Acute graft versus host disease Intracranial calcification Non-Hodgkin's lymphoma Blood iron increased Acute on chronic liver failure Cryoglobulinaemia Small intestine leiomyosarcoma More trials…

Learn about Rare Diseases

Atypical haemolytic uraemic syndrome – Diagnostics Hereditary hypophosphataemic rickets – Trials in Disease Sjogren’s syndrome Glomerulonephritis membranous – Trials in Disease Mantle cell lymphoma refractory – Trials in Disease Glomerulonephritis rapidly progressive – Trials in Disease Hairy cell leukaemia recurrent – Basic Information Hypereosinophilic syndrome – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Diagnostics Medulloblastoma recurrent – Life with Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Siponimod Fumaric Acid Argatroban Monohydrate Lomustine Sotagliflozin Naloxone Hydrochloride Gemcitabine Hydrochloride ZINC GLUCONATE TRIACYLGLYCEROL LIPASE Camonsertib Linsitinib Ropivacaine Hydrochloride Cefaclor Gskvx000000008885 Human Mesenchymal Stem Cells 2,4 DICHLOROBENZYL ALCOHOL Rtx001 Amisulpride 18F-Fludarabine Imipenem Anhydrate Abacavir More therapies…

Learn about Your Condition

Hepatocellular carcinoma Chronic coronary syndrome Plasma cell myeloma recurrent Leukaemia Peripheral artery angioplasty Overweight Cerebral palsy Papilloma viral infection Behcet's syndrome Asthma Pemphigus Colon cancer stage III Dyspnoea Primary myelofibrosis Delirium More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Malignant melanoma stage III

Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation

Not recruiting

3 1 1
Investigated Drugs:
+5
Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with BRAF V600E/K Mutation-Positive Melanoma After Anti-PD-1 Therapy

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study Comparing Ipilimumab and Nivolumab with Standard Nivolumab for Patients with Stage III Melanoma

Not recruiting

3 1 1 1
Investigated Diseases:
- Malignant melanoma stage III
- Malignant melanoma
Investigated Drugs:
- Ipilimumab
- Nivolumab
Study on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery

Not recruiting

3 1 1
Investigated Drugs:
- Pembrolizumab
+7

1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Malignant melanoma stage III

Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation

Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with BRAF V600E/K Mutation-Positive Melanoma After Anti-PD-1 Therapy

Study Comparing Ipilimumab and Nivolumab with Standard Nivolumab for Patients with Stage III Melanoma

Study on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies